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Introduction: In malignant lymphoma, cardiac involvement, which usually forms pathologically focal and firm
nodules in the cardiac walls, is considered to be a late manifestation of the disease.
Case presentation: We describe the case of a 71-year-old Asian Japanese woman whose first presentation of
lymphoma was congestive heart failure. Multiple imaging examinations and laboratory findings led to a presumed
diagnosis of a malignant lymphoma. A tissue diagnosis of the mediastinal mass could not be performed due to our
patient’s generally poor condition. Our patient received corticosteroid therapy, but died 42 days after her admission.
An autopsy revealed lymphoid cells encircling her ventricular wall and infiltrating her endocardium. A histological
examination confirmed the diagnosis of diffuse large B-cell lymphoma.
Conclusion: Imaging examinations such as echocardiography, computed tomography with three-dimensional
reconstruction, and gallium-67-citrate scintigraphy could clearly detect the diffuse cardiac involvement antemortem.
A combination of these imaging techniques could provide a working diagnosis and allow empirical initiation of
treatment in patients with poor general condition.Introduction
Cardiac tumors have many clinical presentations and
have many differential diagnoses (Table 1). Among these
cardiac tumors, metastatic cardiac tumors are relatively
more common than primary cardiac tumors. Metastases
to the heart were found in 1.23% of 12,485 consecutive
autopsies, compared with a 0.056% prevalence of pri-
mary cardiac tumors [1-3].
Cardiac involvement of a malignant lymphoma is usu-
ally a late manifestation of the disease; therefore, cardiac
failure as the initial presentation is extremely rare [4,5].
It is difficult to make a definite diagnosis of these cases,
because a surgical biopsy usually cannot be performed
due to the risk of cardiac failure. Therefore, most of
these patients have died before starting chemotherapy
and are only diagnosed postmortem.* Correspondence: watta@juntendo.ac.jp
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reproduction in any medium, provided the orA malignant lymphoma with cardiac involvement usu-
ally leads to the formation of focal masses in the cardiac
wall, and the diffuse involvement pattern is uncommon.
Moreover, diffuse cardiac involvement generally cannot
be detected by simple imaging examinations such as
chest X-ray or usual computed tomography (CT) [6].
We present the case of a patient with a malignant
lymphoma with diffuse cardiac involvement whose first
presentation was congestive heart failure. A definitive
diagnosis was not obtained antemortem because of our
patient’s poor general condition. However, a combin-
ation of several imaging modalities, including echocardi-
ography, CT with three-dimensional CT reconstruction
and nuclear scanning, could detect the diffuse cardiac
involvement, and the findings were similar to the aut-
opsy findings.
Case presentation
A 71-year-old Asian Japanese woman was admitted to
our hospital complaining of cough, dyspnea and periph-
eral edema that had lasted for several weeks. On physicall Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Differential diagnosis of cardiac tumors
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http://www.jmedicalcasereports.com/content/6/1/193examination, she had a low-grade fever, an irregular
heartbeat and hypertension, and an oxygen saturation of
92% with 2L/min via a nasal cannula. Peripheral lymph-
adenopathy and hepatosplenomegaly were absent.
Our patient’s white blood cell count was 9.4 × 109/L,
with 92.0% neutrophils, 3.5% lymphocytes, 4.0% mono-
cytes and 0.5% basophils. She had elevated levels of C-








Figure 1 Imaging studies. (A) Echocardiography revealed a high echoic r
tomography scan on admission revealed a mediastinal mass, pericardial no
Three-dimensional computed tomography reconstruction imaging revealed
pulmonary artery; PE: pericardial effusion; Pl E: pleural effusion; RV: right vensoluble interleukin-2 receptor (2,220U/mL, normal range:
145 to 519U/mL) and N-terminal pro-B-type natriuretic
peptide (2,795.0pg/mL; normal range <125.0pg/mL).
Virological tests related to myocarditis were negative
and her angiotensin-converting enzyme level, associated
with sarcoidosis, was normal. Electrocardiography showed
atrial fibrillation but no evidence of any ischemic changes.
Furthermore, echocardiography showed normal systolic
function of her left ventricle (ejection fraction of 65%)
though the diastolic function was moderately impaired
(pseudonormal) due to an impairment of myocardial re-
laxation [7]: the ratio of the peak early diastolic filling vel-
ocity to the peak atrial filling velocity (E/A ratio) was
increased to 1.6 in spite of the advanced age of our pa-
tient. The deceleration time did not decrease (174msec).
The peak early diastolic velocity (e’) did decrease to
8.2cm/s, while the ratio of the peak early diastolic filling
velocity to the peak early diastolic velocity (E/e’ ratio)
increased to 11.0. In addition, echocardiography revealed
a diffuse and high echoic mass outside of the ventricular
wall with pericardial effusion, which was originally
thought to be a fibrin clot (Figure 1A, arrow head).
Chest X-rays showed bilateral pleural effusion with
mediastinal widening. A CT scan of her body trunk was
performed to better characterize the lesion anatomically,
and this revealed a mediastinal mass and pericardial
nodules, as well as pericardial and pleural effusion
(Figure 1B, C). Additionally, three-dimensional CT re-
construction (Figure 1D) showed the presence of a






egion outside the ventricular wall (arrow head). (B, C) The computed
dules (arrow head), and pericardial and bilateral pleural effusions. (D)
the rough surface of the epicardium. Ao: aorta; LV: left ventricle; PA:
tricle.
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eral lung fields or within the thoracic wall.
We next performed gallium-67-citrate (67Ga) scintig-
raphy to test for the existence of lymph nodes in order
to make a tissue diagnosis. The 67Ga uptake was
observed in the mediastinal lymph nodes, but not in
other lymph nodes. Interestingly, 67Ga uptake was dif-
fusely seen in the heart (Figure 2A).
Pericardial and bilateral pleural effusions were drawn
and found to be bloody, with an exudate pattern and no
malignant findings on cytology. A bacterial culture
revealed no microorganisms. Additionally, a flow cyto-
metric analysis of both types of effusions showed pre-
dominant lymphocytes (B-cell to T-cell ratio of 1:4);
however, there was no monoclonal pattern.
A surgical biopsy of the mediastinal mass was consid-
ered to achieve a pathological diagnosis. However, be-
cause our patient’s respiratory condition was extremely
poor, neither the surgical biopsy, including thoracoscopy,
nor the transarterial catheter biopsy could be performed.
The most probable diagnosis was a malignant lymphoma
because of the presence of a mediastinal mass and an
elevated soluble interlukin-2 receptor level, which is ele-
vated in patients with non-Hodgkin lymphoma [8]. Fur-
thermore, differential diagnoses, such as myocarditis,
tuberculosis and other malignant tumors, bronchogenic
carcinoma, mesothelioma and melanoma were extremely
unlikely based on the results of the laboratory and im-




Figure 2 Gallium-67-citrate scintigraphy and postmortem specimen e
increased uptake by only the thoracic lymph nodes and the heart. (B, C) T
involvements (*) of the epicardium (B) and the mediastinum (C). Of note, s
(D) A histological section of the mediastinal lymph node demonstrated de
cytoplasm. (Hematoxylin and eosin stain ×100.) Ao: aorta; LV: left ventricle;prednisolone, which is one of the antitumor medicines
for a malignant lymphoma, due to her poor performance
status and undiagnosed condition. However, the cortico-
steroid therapy failed to reduce the tumor size at least
until day 16, when our patient’s condition gradually
deteriorated and she subsequently died of cardiac failure.
An autopsy was performed after permission was
obtained from her family. The macroscopic evaluation
during the autopsy revealed that the mediastinal mass
consisted of a cluster of enlarged lymph nodes. A num-
ber of disseminated masses were found on the pericar-
dial membrane. These involvements had encircled the
ventricle walls and penetrated through the cardiac layers
to her endocardium (Figure 2B, C).
On microscopy, the mediastinal lymph nodes demon-
strated a complete effacement of the normal architecture
because of the dense proliferation of large blastoid cells.
These cells resembled normal centroblasts, and showed
large and non-cleaved cells with vesicular chromatin
(Figure 2D). The immunohistochemical staining showed
that the tumor cells were positive for cluster of differen-
tiation (CD)20, CD79a, paired box 5 and B-cell lymph-
oma 2, and negative for CD3, CD4, CD5, CD8,
CD45RO, CD56, multiple myeloma oncogene 1 and cyc-
lin D1. Accordingly, the final diagnosis was established
as mediastinal diffuse large B-cell lymphoma. The pre-
sumed cause of death was the impairment of cardiac




xamination. (A) Anterior (left) and posterior (right) 67Ga scans showed
he cut surface of the heart at autopsy revealed lymphomatous
ome of the involvements had infiltrated into the endocardium (arrow).
nse proliferation of large centroblastic cells with abundant pale
RV: right ventricle.
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Cardiac involvement is observed in around 20% of patients
with advanced stage malignant lymphoma, according to a
series of autopsies [9]. However, cases with cardiac involve-
ment that show cardiac failure at initial presentation are
extremely rare, requiring a high level of suspicion for diag-
nosis, and result in a poor prognosis for the patient [4].
Cardiac involvement is generally reported to include the
formation of focal and firm nodules in the cardiac walls
and/or the pericardium. In our case, the cardiac involve-
ments did not show any nodular lesions, but the cardiac
wall was diffusely encircled. Diffuse cardiac involvement of
a malignant lymphoma has been reported in only a few
cases [6,10,11]. Most of them showed some signs of car-
diac failure as the initial symptom, and could not be diag-
nosed antemortem, as in our case [10,11]. Based on these
reports, diffuse cardiac involvement is typically associated
with uniform infiltration into the myocardium. However,
to the best of our knowledge, diffuse cardiac involvements
encircling the ventricle, as in our patient, has not yet been
reported. Imaging examinations such as echocardiography,
CT (including three-dimensional CT reconstruction) and
nuclear scanning were employed in these cases to detect
the cardiac involvements.
Echocardiography has been reported to be a useful
examination for evaluating the cardiac involvement of
malignant lymphomas showing a mass lesion, pericardial
effusion and thickened ventricular wall [4]. Echocardiog-
raphy detected the cardiac involvement in our case as
well. A high echoic mass outside of the ventricle
encircled our patient’s heart. Additionally, the diastolic
dysfunction of her left ventricle was revealed, caused by
impaired myocardial relaxation. These echocardio-
graphic findings have not yet been reported in other
cases. Therefore, echocardiography may also be useful
for detecting cardiac involvement in terms of imaging
the inner structure of the cardiac wall and also for evalu-
ating cardiac function.
In contrast, CT scanning did not provide clear images
of the inner structure of the cardiac wall. However, CT
scans could detect mediastinal lymphadenopathy and, in
particular, three-dimensional CT reconstruction could
clearly reveal the rough surface of the epicardium. In
addition, three-dimensional CT reconstruction can dis-
play stereoscopic images that are useful for understand-
ing the spatial relationship between the tumor and the
anatomical structures, as was demonstrated in our case.
Therefore, three-dimensional CT reconstruction is a
useful imaging method for determining the cardiac in-
volvement of a malignant lymphoma. To the best of our
knowledge, the utility of three-dimensional CT recon-
struction for cardiac involvement of a malignant lymph-
oma has not yet been reported. 67Ga scintigraphy, a
nuclear scanning examination, could detect diffuseinfiltration of the heart. However, the diagnostic sensitiv-
ity of nuclear scanning was lower than that of CT be-
cause of the low-resolution nature of the images.
Therefore, it is important to combine nuclear scanning
with other imaging methods when assessing the lympho-
matous involvement of the heart. In recent years, 18F-
Fluorodeoxyglucose positron-emission tomography
(18FDG-PET), which is another form of nuclear scan-
ning, appears to be more sensitive for detecting nodal
and extranodal involvements than 67Ga scintigraphy
[12]. Furthermore, CT and 18FDG-PET have been
recommended for the pre- and post-treatment evalu-
ation of nodal diffuse large B-cell lymphoma because of
their high sensitivity [13]. However, 18FDG-PET scan-
ning could not be conducted in this case because it
could not be performed in our hospital and our patient’s
general condition was too serious for transfer to another
hospital. 67Ga scanning, which was formerly the stand-
ard technique, could detect the lymphomatous involve-
ments of the heart [12]. Therefore, nuclear scanning
should be performed in cases of suspected lymphoma.
The imaging modalities we employed provided, in con-
junction, clear evidence of the cardiac involvement and
raised a reasonable suspicion of a malignant lymphoma.
In light of our patient’s poor condition that precluded a
pathologic diagnosis, we were compelled to act upon
this suspected diagnosis and initiated corticosteroid
therapy. While in the case of our patient, the interven-
tion was not able to prolong survival, a younger patient
in better general health might have benefited from such
a diagnosis.
Conclusion
The patient presented here had a rare case of malignant
lymphoma with diffuse cardiac involvement that initially
presented as cardiac failure. Diffuse cardiac involvement
of malignant lymphoma may result in cardiac dysfunc-
tion and a poor prognosis. Some imaging techniques can
be noninvasively applied in these serious cases and cor-
rectly image the cardiac involvement. Echocardiography
can detect cardiac involvement, including the inner
structure of the cardiac wall and the impairment of car-
diac function caused by these structures; CT with three-
dimensional reconstruction can survey the lymphoma-
tous involvement, including the epicardial surface; and
nuclear scanning can provide information suggesting
whether or not the mass is malignant. A combination of
these imaging techniques can strongly suggest lympho-
matous involvement of the heart, providing a working
diagnosis and allowing empirical initiation of treatment.
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